Home > News > Biophan Technologies CEO Michael Weiner to Present Company Strategy
September 14th, 2004
Biophan Technologies CEO Michael Weiner to Present Company Strategy
Abstract:
Michael Weiner, CEO of Biophan Technologies, Inc. a developer of next-generation biomedical technology, is slated to present an overview of the Company's strategy and extensive intellectual property portfolio to potential investors at Friedland Capital's "Undervalued Equities Conference" in New York City today, the Company has announced.
Source:
Businesswire
Related News Press |
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||